AiMeD expresses dismay over FICCI’s ‘Un-Make in India’ drive
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
AIIMS established in Bilaspur, Nagpur, Rae Bareli and Gorakhpur
Traditional medicine effectively highlighted in all health and engagement working groups meeting and Ministry of Ayush acknowledges these efforts
Subscribe To Our Newsletter & Stay Updated